QA: Skye Bioscience Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2017_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 279,489
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,584
3 remainder_Assets 34,290
4 LiabilitiesCurrent 661,958
5 LiabilitiesNoncurrent 1,112,308
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,531,540
9 ResearchAndDevelopmentExpense 939,040
10 remainder_Expenses -1,341,051
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 323,363
1 Liabilities 1,774,266
2 Expenses 3,129,529
3 Revenues 0
4 StockholdersEquity -1,450,903
5 NetIncome -3,129,529
6 ComprehensiveNetIncome -3,129,529
7 BaseVar 2,613,579
8 EconomicCapitalRatio -5.36

Edgar->Model Mapping

Feature Distribution